Ragosa Mark's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Jan 9, 2026
- Accession no.
- 0001835458-26-000002
- Filed
- Jan 9, 2026
- Trade date
- Jan 8, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $502.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ragosa MarkCIK 0001835458 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Class A Ordinary Share | SSaleDisposed | −12,000 | $41.89 | −$502,680 | 19,086 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.